- 3.4Impact Factor
- 9.9CiteScore
- 20 daysTime to First Decision
Vaccines, Volume 11, Issue 5
May 2023 - 132 articles
Cover Story: Tropical diseases caused by filarial nematodes such as lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness) affect hundreds of millions of people worldwide. Despite decades of research, no vaccines against any filaria or helminths in general are available for use in human patients as of 2023. In this study by Scheunemann et al., the use of nucleic acid receptor agonists as potential vaccine adjuvants for filarial infections was evaluated in the Litomosoides sigmodontis rodent model. The authors reported that the use of poly(I:C), a TLR-3, MDA5, RIG-I ligand, and 3pRNA, a RIG-I ligand, improved the protective efficacy in comparison to the vaccination with irradiated L3 larvae alone and elicited stronger parasite-specific immune responses, highlighting the use of nucleic acid receptor agonists as promising vaccine strategies for filarial and other helminth infections. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Vaccines - ISSN 2076-393X